반응 #2140932

ord-b6df985e65a84f64bc5977e5b24d5dd9

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    온도The reaction was refluxed for 3 hours
  2. 2
    기타the solvent was removed
  3. 3
    기타the residue dried in vacuo
  4. 4
    기타The crude acid chloride thus prepared
  5. 5
    세척washed with saturated sodium bicarbonate and brine
  6. 6
    건조The organic phase was dried over anhydrous magnesium sulfate
  7. 7
    여과filtered
  8. 8
    농축concentrated
  9. 9
    기타The residue was purified by flash column chromatography on silica gel
  10. 10
    세척eluting with 5% methanol in chloroform

실험 절차

10-[4-(2-Methyl-cyclohex-1-enyl)-benzoyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxylic acid of Step F (0.0510 g, 0.120 mmol) and oxalyl chloride (0.011mL, 0.126 mmol) were combined in anhydrous dichloromethane (1.2 mL) followed by dropwise addition of N,N-dimethylformamide (0.0003 mL, 0.0036 mmol). The reaction was refluxed for 3 hours, then the solvent was removed and the residue dried in vacuo. The crude acid chloride thus prepared was combined with N-methylpiperazine (0.0146 mL, 0.132 mmol) and N,N-diisopropylethyl amine (0.025 mL, 0.144 mmol) in anhydrous dichloromethane (1.2 mL). After stirring at room temperature overnight, the reaction mixture was diluted with ethyl acetate and washed with saturated sodium bicarbonate and brine. The organic phase was dried over anhydrous magnesium sulfate, filtered and concentrated. The residue was purified by flash column chromatography on silica gel, eluting with 5% methanol in chloroform to afford the title compound (0.025 g) as a white solid from a mixture of diethyl ether and hexane,

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07326700B2uspto-grants-2008_02